1. Home
  2. AMCX vs RCEL Comparison

AMCX vs RCEL Comparison

Compare AMCX & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMCX
  • RCEL
  • Stock Information
  • Founded
  • AMCX 1980
  • RCEL N/A
  • Country
  • AMCX United States
  • RCEL United States
  • Employees
  • AMCX N/A
  • RCEL N/A
  • Industry
  • AMCX Cable & Other Pay Television Services
  • RCEL Medical/Dental Instruments
  • Sector
  • AMCX Telecommunications
  • RCEL Health Care
  • Exchange
  • AMCX Nasdaq
  • RCEL Nasdaq
  • Market Cap
  • AMCX 275.8M
  • RCEL 227.5M
  • IPO Year
  • AMCX 2011
  • RCEL N/A
  • Fundamental
  • Price
  • AMCX $6.02
  • RCEL $9.10
  • Analyst Decision
  • AMCX Sell
  • RCEL Strong Buy
  • Analyst Count
  • AMCX 5
  • RCEL 4
  • Target Price
  • AMCX $7.40
  • RCEL $17.25
  • AVG Volume (30 Days)
  • AMCX 551.3K
  • RCEL 195.4K
  • Earning Date
  • AMCX 05-09-2025
  • RCEL 05-08-2025
  • Dividend Yield
  • AMCX N/A
  • RCEL N/A
  • EPS Growth
  • AMCX N/A
  • RCEL N/A
  • EPS
  • AMCX N/A
  • RCEL N/A
  • Revenue
  • AMCX $2,421,314,000.00
  • RCEL $64,251,000.00
  • Revenue This Year
  • AMCX N/A
  • RCEL $62.33
  • Revenue Next Year
  • AMCX N/A
  • RCEL $30.59
  • P/E Ratio
  • AMCX N/A
  • RCEL N/A
  • Revenue Growth
  • AMCX N/A
  • RCEL 28.14
  • 52 Week Low
  • AMCX $5.41
  • RCEL $6.90
  • 52 Week High
  • AMCX $18.58
  • RCEL $14.16
  • Technical
  • Relative Strength Index (RSI)
  • AMCX 40.16
  • RCEL 55.11
  • Support Level
  • AMCX $5.75
  • RCEL $8.79
  • Resistance Level
  • AMCX $6.15
  • RCEL $9.36
  • Average True Range (ATR)
  • AMCX 0.41
  • RCEL 0.68
  • MACD
  • AMCX 0.03
  • RCEL 0.14
  • Stochastic Oscillator
  • AMCX 38.29
  • RCEL 86.11

About AMCX AMC Networks Inc.

AMC Networks owns several linear pay-TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network, reached 60 million pay-TV households in the US at the end of 2024. The firm also had nearly 12.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: